Infectious Mononucleosis (Mono) Transmission: EBV Dynamics, Shedding, and Prevention
Infectious mononucleosis is caused by Epstein-Barr virus (EBV, HHV-4), a gammaherpesvirus establishing lifelong latency in B lymphocytes. Transmission dynamics are distinct from acute respiratory viruses.
Transmission Mechanics
- Primary vehicle: Saliva (hence "kissing disease").
- Viral shedding: High titers in oropharyngeal secretions during acute illness (10⁴–10⁶ copies/mL).
- Secondary routes: Genital secretions (sexual transmission documented), blood transfusion (rare, screened), hematopoietic transplant.
- Not transmitted by: Casual contact, aerosols, fomites (desiccation-sensitive enveloped virus).
Shedding Timeline & Infectivity
| Phase | Duration | Salivary Shedding | Transmission Risk |
|---|---|---|---|
| Incubation | 4–6 weeks | Low/undetectable | Low |
| Acute illness | 2–4 weeks | Peak (high titer) | Highest |
| Convalescence | Weeks to months | Declining, intermittent | Moderate → low |
| Latency (asymptomatic) | Lifelong | Intermittent reactivation | Low but non-zero |
Asymptomatic Reactivation & Transmission
- 15–25% of seropositive adults shed EBV in saliva at any time.
- Triggers: Stress, immunosuppression, hormonal changes, other infections.
- Asymptomatic shedding → transmission to seronegative partners possible.
- Most adults (90–95%) are already seropositive → reinfection not disease-causing.
Clinical Presentation Spectrum
- Classic mono (adolescents/young adults): Fever, pharyngitis, lymphadenopathy, fatigue, splenomegaly, atypical lymphocytosis.
- Children: Often asymptomatic or mild URI.
- Older adults: Atypical; less pharyngitis, more hepatic involvement, prolonged fatigue.
- Complications: Splenic rupture (0.1–0.5%), airway obstruction, hepatitis, neurologic (GBS, encephalitis), hematologic (AIHA, thrombocytopenia).
Prevention & Partner Guidance
- During acute illness: Avoid kissing, sharing cups/utensils/toothbrushes.
- Sexual transmission: Condoms reduce but don't eliminate (saliva contact during intimacy).
- No vaccine available (candidates in trials; gp350 subunit).
- Partner counseling: Most adults immune; if partner seronegative, delay intimate contact until symptoms resolve + 2 weeks.
- Sports clearance: No contact sports × 3–4 weeks (splenic rupture risk); ultrasound not routine for clearance.
Diagnosis
- Heterophile antibody (Monospot): 85% sensitive, 95% specific; false neg <15y, >60y.
- EBV-specific serology: VCA-IgM (acute), VCA-IgG (past), EBNA-IgG (past >3–6 mo).
- EBV PCR: Quantitative; not routine for diagnosis; used in transplant/immunocompromised.
Prescription Medications - Related Articles
- Blood Pressure Medications & Liver Health: What You Need to Know
- Lovenox Bridging: A Guide for Safe Surgical Procedures
- Medco: Prescription Services & Mail-Order Pharmacy | [Company Name]
- Understanding Phenytoin Dosage: A Guide for Epilepsy Patients
- Taking 3 Birth Control Pills in One Day: Overdose Risk and What to Do
- Safely Open Glass Ampules: A Step-by-Step Guide
- Pop Eye in Fish: Causes, Treatment, and Veterinary Care
